Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
In a systematic review of 26 randomized controlled trials involving over 15,000 participants, tirzepatide demonstrated weight reduction of 17.8% at 72 weeks, while newer agents like retatrutide achieved up to 22.1% reduction at 48 weeks, providing clinicians with expanded options for pharmacological weight management.
Endocrinology, Diabetes, Metabolism February 6th 2025
Verywell Health
Research shows tirzepatide users achieve up to 25% body weight reduction, driving social media users to seek accessible alternatives through unproven natural remedies.
Epoch Health
Each plastic tea bag releases billions of micro- and nanoplastic particles during brewing, with evidence suggesting these particles can reach cell nuclei within 24 hours of exposure.
Family Medicine/General Practice February 6th 2025
Clinical Advisor
Understanding the distinction between probable cause for arrest and evidence required for conviction is crucial for prescribers managing controlled substances.
Clinical Pharmacology February 6th 2025
MDLinx
Medical bias can lead to missed diagnoses when physicians default to weight-related assumptions rather than conducting comprehensive evaluations.
Emergency Medicine February 5th 2025
Medical Xpress
Heavy cannabis users showed reduced activity in key brain regions associated with working memory, with 63% demonstrating measurable changes in cognitive function during specific tasks.
Family Medicine/General Practice February 5th 2025